Researchers might be skeptical and, with people’s lives at stake, that’s understandable. Here’s how to take advantage of the advances while ensuring safeguards are in place.
As artificial intelligence (AI) and machine learning drive innovation and disruption in clinical trials and precision medicine, questions around the responsible use of AI have moved to the forefront of debates among healthcare stakeholders – patients, providers, regulatory authorities, payors and sponsors. To what extent,
Read More
AI
AI in Healthcare| AI Impact for Researchers, Clinicians| Policy, News, Analysis, Insights - HIT Consultant
DarioHealth Acquires Physimax, AI-Powered Musculoskeletal Self-Assessment and Optimization Platform
What You Should Know:
- Global digital therapeutics (DTx) company DarioHealth Corp. (Nasdaq: DRIO), a leader in the market (the Company), announced it has entered into an agreement to purchase all of the right, title and interest in certain assets of Physimax Technologies Ltd. ("Physimax"), a leading provider of computer vision (CV) technology for Musculoskeletal (MSK) functional screening and predictive risk of injury assessment.
- This acquisition complements DarioHealth’s existing MSK
Read More
7 Burning Questions from Life Sciences Companies on Using AI Agents
Each day life science companies respond to numerous medical information inquires – many of which are similar in nature or can be simply addressed. However, as we have seen in the news reports with the Great Resignation and many workers searching for new careers, the number of individuals interested in working in a medical information contact center may be waning. When you combine this with the rising volume of inquiries or medical inquiries and patient expectations for a real-time response to
Read More
Sema4 Acquires GeneDx for $623M to Strengthen AI-Driven Genomic Platform
What You Should Know:
- Today, Sema4 (Nasdaq: SMFR), a health intelligence company, announced it has signed a definitive agreement to acquire GeneDx, a leader in genomic testing and analysis, at a purchase price representing approximately $623 million, strengthening its market-leading health intelligence and genomic screening offerings.
- The combined company is projected to deliver $350 million in pro forma 2022 revenue. In connection with the acquisition,
Read More
How Will AI Continue to Shape Healthcare in 2022? 9 Predictions to Watch
Digital health executives share their predictions on how artificial intelligence (AI) will continue to shape the healthcare industry in 2022.
Diana Nole, EVP and GM of Healthcare at Nuance Communications, Inc.
AI will find more game-changing use cases – According to Optum's fourth annual survey on AI in healthcare, 96% of respondents said AI plays an important role in increasing health equity, and 94% said they have a duty to ensure AI is used responsibly in healthcare. As healthcare
Read More
Headspace Acquires AI Mental Health Startup Sayana
What You Should Know:
- Headspace Health, today announced the acquisition of Sayana, an AI-driven mental health and wellness company. With this acquisition, Headspace Health is expanding its ability to provide highly-personalized mental health care and content to its millions of users in 190+ countries.
- The acquisition comes approx. 6 months after the $3B merger of Headspace and Ginger, and will add further AI capabilities to what is the most accessible and comprehensive digital
Read More
We Recall Drugs with Adverse Effects, So Why Not Recall AI Algorithms with Racial Bias?
Over the last decade, AI has transformed from a futuristic, hype-driven tool, to now being a daily part of our lives. We use AI for everything from unlocking our smartphones, to evaluating our credit scores, to helping clinicians make patient care decisions. In particular, the potential of AI to transform drug development and patient care is unparalleled – its ability to gather objective insights can help elevate a clinical trial’s data and bring potentially life-saving drugs to people in need
Read More
Protai Nabs $8M for AI-Powered Drug Discovery Platform
What You Should Know:
- Protai, a Tel Aviv, Israel-based AI-powered drug discovery startup, today announced its emergence from stealth, along with an $8 million seed financing round co-led by Grove Ventures and Pitango HealthTech.
- Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases.
Proteomics-based Platform for Faster and More Accurate Drug Discovery
Despite the significant
Read More
Using Real-World Evidence (RWE) & AI to Enable Better Clinical Care
During the prescribing process, a physician’s ability to accurately and reliably match the most appropriate therapy option with the patient at hand is limited by the amount and quality of clinical information that is available. While randomized clinical trials are considered the gold standard for establishing the safety and efficacy of prescription medications, and the clinical findings verified from the trial inform the label on the approved therapy, the overall utility of such trials is
Read More
Nuance Launches Precision Imaging Network for AI-Powered Imaging Insights
What You Should Know:
Nuance launches Precision Imaging Network, a new AI-powered cloud-based platform for radiologists.
Nuance® Communications, Inc. (NASDAQ: NUAN) launched the Nuance Precision Imaging Network, an AI-powered cloud platform that delivers patient-specific data and insights from diagnostic imaging into existing clinical and administrative workflows across the healthcare ecosystem. Leveraging the scale
Read More
